BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohet C, Haguinet F, Dos Santos G, Webb D, Logie J, Lc Ferreira G, Rosillon D, Shinde V. Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series. BMJ Open 2016;6:e009264. [PMID: 26823177 DOI: 10.1136/bmjopen-2015-009264] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Laupèze B, Hervé C, Di Pasquale A, Tavares Da Silva F. Adjuvant Systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood. Vaccine 2019;37:5670-80. [PMID: 31420171 DOI: 10.1016/j.vaccine.2019.07.098] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
2 Mombelli M, Rettby N, Perreau M, Pascual M, Pantaleo G, Manuel O. Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial. Vaccine. 2018;36:6163-6169. [PMID: 30181045 DOI: 10.1016/j.vaccine.2018.08.057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
3 Bosaeed M, Kumar D. Seasonal influenza vaccine in immunocompromised persons. Hum Vaccin Immunother 2018;14:1311-22. [PMID: 29485353 DOI: 10.1080/21645515.2018.1445446] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
4 Blumenthal KG, Lu N, Zhang Y, Li Y, Walensky RP, Choi HK. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ 2018;361:k2400. [PMID: 29950489 DOI: 10.1136/bmj.k2400] [Cited by in Crossref: 97] [Cited by in F6Publishing: 91] [Article Influence: 24.3] [Reference Citation Analysis]
5 Paulsen GC, Danziger-Isakov L. Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:707-26. [PMID: 29128020 DOI: 10.1016/j.ccm.2017.07.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
6 Hirzel C, Kumar D. Influenza vaccine strategies for solid organ transplant recipients. Curr Opin Infect Dis 2018;31:309-15. [PMID: 29771697 DOI: 10.1097/QCO.0000000000000461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 5.3] [Reference Citation Analysis]
7 Cohet C, van der Most R, Bauchau V, Bekkat-berkani R, Doherty TM, Schuind A, Tavares Da Silva F, Rappuoli R, Garçon N, Innis BL. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. Vaccine 2019;37:3006-21. [DOI: 10.1016/j.vaccine.2019.04.048] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 12.7] [Reference Citation Analysis]
8 Danziger‐isakov L, Kumar D; The AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13563] [Cited by in Crossref: 133] [Cited by in F6Publishing: 103] [Article Influence: 44.3] [Reference Citation Analysis]
9 Bell SA, Iwashyna TJ, Zhang X, Chen B, Davis MA. All-Cause Hospitalizations after Large-Scale Hurricanes among Older Adults: A Self-Controlled Case Series Study. Prehosp Disaster Med 2021;36:25-31. [PMID: 33198843 DOI: 10.1017/S1049023X20001387] [Reference Citation Analysis]
10 Nevermann N, Wiering L, Wu H, Moroder P, Brandl A, Globke B, Krenzien F, Raschzok N, Schöning W, Lurje G, Öllinger R, Schmelzle M, Pratschke J, Ritschl PV. Transplantation programs facing lack of empirical evidence on SARS-CoV-2 vaccination: A society recommendation consensus update. Transpl Infect Dis 2021;:e13696. [PMID: 34288294 DOI: 10.1111/tid.13696] [Reference Citation Analysis]
11 Dos Santos G, Seifert HA, Bauchau V, Shinde V, Barbeau DM, Cohet C. Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt. Drug Saf 2017;40:693-702. [PMID: 28417321 DOI: 10.1007/s40264-017-0532-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Willame C, Baril L, van den Bosch J, Ferreira GL, Williams R, Rosillon D, Cohet C. Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies. Pharmacoepidemiol Drug Saf 2016;25:1397-406. [PMID: 27601179 DOI: 10.1002/pds.4081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Dos Santos G, Haguinet F, Cohet C, Webb D, Logie J, Ferreira GL, Rosillon D, Shinde V. Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series. Vaccine 2016;34:3598-606. [DOI: 10.1016/j.vaccine.2016.05.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
14 Chong PP, Avery RK. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients. Clinical Therapeutics 2017;39:1581-98. [DOI: 10.1016/j.clinthera.2017.07.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
15 Cordero E, Bulnes-Ramos A, Aguilar-Guisado M, González Escribano F, Olivas I, Torre-Cisneros J, Gavaldá J, Aydillo T, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Roca C, Lara R, Pérez-Romero P. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients. Front Immunol 2020;11:1917. [PMID: 33123119 DOI: 10.3389/fimmu.2020.01917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Cohet C, Rosillon D, Willame C, Haguinet F, Marenne MN, Fontaine S, Buyse H, Bauchau V, Baril L. Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view. Vaccine 2017;35:3041-9. [PMID: 28465097 DOI: 10.1016/j.vaccine.2017.04.058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Mulley WR, Dendle C, Ling JEH, Knight SR. Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant. 2018;37:844-852. [PMID: 29609844 DOI: 10.1016/j.healun.2018.03.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]